(Press-News.org) Contact information: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
A natural sugar delivers DNA aptamer drug inside tumor cells
New Rochelle, NY, January 27, 2014—Drugs comprised of single strands of DNA, called aptamers, can bind to targets inside tumor cells causing cell death. But these DNA drugs cannot readily get inside tumor cells on their own. Effective delivery of DNA aptamers using a natural polysaccharide as a carrier is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available on the Nucleic Acid Therapeutics website.
Tatyana Zamay and coauthors, Krasnoyarsk State Medical University, Siberian Branch Russian Academy of Sciences, and Center for Reproductive Medicine (Krasnoyarsk, Russia), and University of Ottawa, Canada, combined the polysaccharide arabinogalactan, obtained from the larch tree, with a DNA drug that binds to and disrupts the activity of vimentin, a structural protein required for cell division. Vimentin is often over-produced by tumor cells compared to normal cells.
In the article "DNA-Aptamer Targeting Vimentin for Tumor Therapy in Vivo" the authors show that an aptamer targeting vimentin inhibits tumor growth more effectively when it is administered as a mixture with arabinogalactan than alone.
"This work demonstrates the advancement of aptamer therapeutic application through increased bioavailability using a nontoxic polysaccharide based therapy," says Executive Editor Graham C. Parker, PhD.
INFORMATION:
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Graham C. Parker, PhD.
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the official journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website.
About the Society
The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia-and industry-based research and development of oligonucleotide therapeutics. The society brings together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including Human Gene Therapy, Human Gene Therapy Methods, Human Gene Therapy Clinical Development, ASSAY and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
http://www.liebertpub.com
A natural sugar delivers DNA aptamer drug inside tumor cells
2014-01-27
ELSE PRESS RELEASES FROM THIS DATE:
Solving a 30-year-old problem in massive star formation
2014-01-27
An international group of astrophysicists has found evidence strongly supporting a solution to a long-standing puzzle about the birth of some of the most massive stars in the universe.
Young massive ...
Successful regeneration of human skeletal muscle in mice
2014-01-27
Baltimore, Md. (January 27, 2014) – Researchers at the Kennedy Krieger Institute recently announced study findings showing ...
Good outcomes with staged surgery for epilepsy in children
2014-01-27
Philadelphia, Pa. (January 27, 2014) – A staged approach to epilepsy surgery—with invasive brain monitoring ...
Mayo Clinic study finds standardized protocol and surgery improve mortality outcomes
2014-01-27
MANKATO, Minn. — Jan. 27, 2014 — For patients who have experienced a large stroke that ...
HIV medications dialogue differs by race, ethnicity
2014-01-27
PROVIDENCE, R.I. [Brown University] — A lot of evidence shows that a patients' race or ethnicity is associated with differences in how health care providers communicate with them, the health care they receive, ...
Study identifies high level of 'food insecurity' among college students
2014-01-27
CORVALLIS, Ore. – One of the few studies of its type has found that a startling 59 percent of college students at one Oregon university were "food insecure" at ...
Graphene-like material made of boron a possibility, experiments suggest
2014-01-27
PROVIDENCE, R.I. [Brown University] — Researchers from Brown University have shown experimentally that a boron-based competitor to graphene is a very real possibility.
Graphene has been heralded ...
Drug to reverse breast cancer spread in development
2014-01-27
Researchers at Cardiff University are developing a novel compound known to reverse the spread of malignant breast cancer ...
Blue eyes and dark skin, that's how the European hunter-gatherer looked
2014-01-27
La Braña 1, name used to baptize a 7,000 years ...
Engineers teach old chemical new tricks to make cleaner fuels, fertilizers
2014-01-27
University researchers from two continents ...